Abstract

Current technologies to generate CRISPR/Cas gene perturbation reagents are labor intense and require multiple ligation and cloning steps. Furthermore, increasing gRNA sequence diversity negatively affects gRNA distribution, leading to libraries of heterogeneous quality. Here, we present a rapid and cloning-free mutagenesis technology to efficiently generate covalently-closed-circular-synthesized (3Cs) CRISPR/Cas gRNA reagents that uncouples sequence diversity from sequence distribution. We demonstrate fidelity and performance of 3Cs reagents by tailored targeting of all human deubiquitinating enzymes (DUBs) and identify their essentiality for cell fitness. To explore high-content screening, we aimed at generating the up-to-date largest gRNA library to simultaneously interrogate the coding and noncoding human genome and identify genes, predicted promoter flanking regions, transcription factor and CTCF binding sites linked to doxorubicin resistance. Our 3Cs technology enables fast and robust generation of bias-free gene perturbation libraries with yet unmatched diversities and should be considered an alternative to established technologies.

Data availability

All data generated or analysed during this study are included in the manuscript, supplementary files or are available through GitHub or Dryad. NGS data and custom software is available as supplementary files and from Dryad and GitHub. Plasmids encoding oTGW 3Cs-gRNA libraries will be made available through the Goethe University Depository (http://innovectis.de/technologien/goethe-depository/).

The following data sets were generated

Article and author information

Author details

  1. Martin Wegner

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    Competing interests
    Martin Wegner, The Goethe University Frankfurt has filed a patent related to this work on which M.W. is an inventor (WO2017EP84625).
  2. Valentina Diehl

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    Competing interests
    Valentina Diehl, The Goethe University Frankfurt has filed a patent related to this work on which V.D. is an inventor (WO2017EP84625).
  3. Verena Bittl

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    Competing interests
    No competing interests declared.
  4. Rahel de Bruyn

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    Competing interests
    Rahel de Bruyn, The Goethe University Frankfurt has filed a patent related to this work on which R.D.B. is an inventor (WO2017EP84625).
  5. Svenja Wiechmann

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    Competing interests
    Svenja Wiechmann, The Goethe University Frankfurt has filed a patent related to this work on which S.W. is an inventor (WO2017EP84625).
  6. Yves Matthess

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4040-1258
  7. Marie Hebel

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    Competing interests
    No competing interests declared.
  8. Michael GB Hayes

    Department of Medicine, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  9. Simone Schaubeck

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    Competing interests
    No competing interests declared.
  10. Christopher Benner

    Department of Medicine, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  11. Sven Heinz

    Department of Medicine, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  12. Anja Bremm

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1386-0926
  13. Ivan Dikic

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    Competing interests
    Ivan Dikic, is co-founder, shareholder and CEO of Vivlion GmbH in Gründung. Also a senior editor of eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8156-9511
  14. Andreas Ernst

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    Competing interests
    Andreas Ernst, The Goethe University Frankfurt has filed a patent related to this work on which A.E. is an inventor (WO2017EP84625).
  15. Manuel Kaulich

    Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany
    For correspondence
    kaulich@em.uni-frankfurt.de
    Competing interests
    Manuel Kaulich, The Goethe University Frankfurt has filed a patent related to this work on which M.K. is an inventor (WO2017EP84625). Also co-founder, shareholder and CSO of Vivlion GmbH in Gründung.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9528-8822

Funding

Hessisches Ministerium für Wissenschaft und Kunst (IIIL5-518/17.004)

  • Manuel Kaulich

Deutsche Forschungsgemeinschaft (EXC115/2)

  • Manuel Kaulich

Hessisches Ministerium für Wissenschaft und Kunst (IIIL5-519/03/03.001)

  • Manuel Kaulich

Deutsche Forschungsgemeinschaft (EXC147/2)

  • Manuel Kaulich

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, Wegner et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 10,304
    views
  • 1,170
    downloads
  • 35
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Martin Wegner
  2. Valentina Diehl
  3. Verena Bittl
  4. Rahel de Bruyn
  5. Svenja Wiechmann
  6. Yves Matthess
  7. Marie Hebel
  8. Michael GB Hayes
  9. Simone Schaubeck
  10. Christopher Benner
  11. Sven Heinz
  12. Anja Bremm
  13. Ivan Dikic
  14. Andreas Ernst
  15. Manuel Kaulich
(2019)
Circular synthesized CRISPR/Cas gRNAs for functional interrogations in the coding and noncoding genome
eLife 8:e42549.
https://doi.org/10.7554/eLife.42549

Share this article

https://doi.org/10.7554/eLife.42549

Further reading

    1. Cell Biology
    Dharmendra Kumar Nath, Subash Dhakal, Youngseok Lee
    Research Advance

    Understanding how the brain controls nutrient storage is pivotal. Transient receptor potential (TRP) channels are conserved from insects to humans. They serve in detecting environmental shifts and in acting as internal sensors. Previously, we demonstrated the role of TRPγ in nutrient-sensing behavior (Dhakal et al., 2022). Here, we found that a TRPγ mutant exhibited in Drosophila melanogaster is required for maintaining normal lipid and protein levels. In animals, lipogenesis and lipolysis control lipid levels in response to food availability. Lipids are mostly stored as triacylglycerol in the fat bodies (FBs) of D. melanogaster. Interestingly, trpγ deficient mutants exhibited elevated TAG levels and our genetic data indicated that Dh44 neurons are indispensable for normal lipid storage but not protein storage. The trpγ mutants also exhibited reduced starvation resistance, which was attributed to insufficient lipolysis in the FBs. This could be mitigated by administering lipase or metformin orally, indicating a potential treatment pathway. Gene expression analysis indicated that trpγ knockout downregulated brummer, a key lipolytic gene, resulting in chronic lipolytic deficits in the gut and other fat tissues. The study also highlighted the role of specific proteins, including neuropeptide DH44 and its receptor DH44R2 in lipid regulation. Our findings provide insight into the broader question of how the brain and gut regulate nutrient storage.

    1. Cell Biology
    2. Immunology and Inflammation
    Mykhailo Vladymyrov, Luca Marchetti ... Britta Engelhardt
    Tools and Resources

    The endothelial blood-brain barrier (BBB) strictly controls immune cell trafficking into the central nervous system (CNS). In neuroinflammatory diseases such as multiple sclerosis, this tight control is, however, disturbed, leading to immune cell infiltration into the CNS. The development of in vitro models of the BBB combined with microfluidic devices has advanced our understanding of the cellular and molecular mechanisms mediating the multistep T-cell extravasation across the BBB. A major bottleneck of these in vitro studies is the absence of a robust and automated pipeline suitable for analyzing and quantifying the sequential interaction steps of different immune cell subsets with the BBB under physiological flow in vitro. Here, we present the under-flow migration tracker (UFMTrack) framework for studying immune cell interactions with endothelial monolayers under physiological flow. We then showcase a pipeline built based on it to study the entire multistep extravasation cascade of immune cells across brain microvascular endothelial cells under physiological flow in vitro. UFMTrack achieves 90% track reconstruction efficiency and allows for scaling due to the reduction of the analysis cost and by eliminating experimenter bias. This allowed for an in-depth analysis of all behavioral regimes involved in the multistep immune cell extravasation cascade. The study summarizes how UFMTrack can be employed to delineate the interactions of CD4+ and CD8+ T cells with the BBB under physiological flow. We also demonstrate its applicability to the other BBB models, showcasing broader applicability of the developed framework to a range of immune cell-endothelial monolayer interaction studies. The UFMTrack framework along with the generated datasets is publicly available in the corresponding repositories.